| UniProt ID | NR1H2_HUMAN | |
|---|---|---|
| UniProt AC | P55055 | |
| Protein Name | Oxysterols receptor LXR-beta | |
| Gene Name | NR1H2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 460 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Nuclear receptor that exhibits a ligand-dependent transcriptional activation activity. [PubMed: 25661920 Binds preferentially to double-stranded oligonucleotide direct repeats having the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing (DR-4 Regulates cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8; DLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism (By similarity Plays an anti-inflammatory role during the hepatic acute phase response by acting as a corepressor: inhibits the hepatic acute phase response by preventing dissociation of the N-Cor corepressor complex] | |
| Protein Sequence | MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDWVIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGARRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQSQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSPTTSSL ------CCCCCCCCC | 45.05 | 25159151 | |
| 3 | Phosphorylation | -----MSSPTTSSLD -----CCCCCCCCCC | 25.60 | 25159151 | |
| 5 | Phosphorylation | ---MSSPTTSSLDTP ---CCCCCCCCCCCC | 41.06 | 23090842 | |
| 6 | Phosphorylation | --MSSPTTSSLDTPL --CCCCCCCCCCCCC | 21.50 | 25159151 | |
| 7 | Phosphorylation | -MSSPTTSSLDTPLP -CCCCCCCCCCCCCC | 31.23 | 23090842 | |
| 8 | Phosphorylation | MSSPTTSSLDTPLPG CCCCCCCCCCCCCCC | 28.33 | 23090842 | |
| 11 | Phosphorylation | PTTSSLDTPLPGNGP CCCCCCCCCCCCCCC | 31.83 | 23090842 | |
| 25 | Phosphorylation | PPQPGAPSSSPTVKE CCCCCCCCCCCCCCC | 42.80 | 25850435 | |
| 26 | Phosphorylation | PQPGAPSSSPTVKEE CCCCCCCCCCCCCCC | 39.00 | 25850435 | |
| 27 | Phosphorylation | QPGAPSSSPTVKEEG CCCCCCCCCCCCCCC | 29.00 | 25850435 | |
| 29 | Phosphorylation | GAPSSSPTVKEEGPE CCCCCCCCCCCCCCC | 46.27 | 23090842 | |
| 31 | Sumoylation | PSSSPTVKEEGPEPW CCCCCCCCCCCCCCC | 53.15 | - | |
| 126 | Methylation | GARRYACRGGGTCQM CCCCCCCCCCCCCHH | 38.32 | 30760333 | |
| 150 | Ubiquitination | QCRLRKCKEAGMREQ HHHHHHHHHHCCHHH | 54.34 | - | |
| 200 | Phosphorylation | SASGPGASPGGSEAG CCCCCCCCCCCCCCC | 29.96 | 24275569 | |
| 247 | Ubiquitination | RSFSDQPKVTPWPLG CCCCCCCCCCCCCCC | 53.78 | - | |
| 398 | Phosphorylation | VEALQQPYVEALLSY HHHHCCHHHHHHHHH | 13.44 | 28450419 | |
| 404 | Phosphorylation | PYVEALLSYTRIKRP HHHHHHHHHHCCCCH | 25.88 | 28450419 | |
| 406 | Phosphorylation | VEALLSYTRIKRPQD HHHHHHHHCCCCHHH | 23.65 | 28450419 | |
| 409 | Sumoylation | LLSYTRIKRPQDQLR HHHHHCCCCHHHHCC | 55.52 | - | |
| 409 | Sumoylation | LLSYTRIKRPQDQLR HHHHHCCCCHHHHCC | 55.52 | 20159957 | |
| 426 | Phosphorylation | RMLMKLVSLRTLSSV HHHHHHHHHHHHHHC | 23.67 | 24719451 | |
| 447 | Sumoylation | ALRLQDKKLPPLLSE HHHHCCCCCCCHHHH | 74.62 | - | |
| 447 | Sumoylation | ALRLQDKKLPPLLSE HHHHCCCCCCCHHHH | 74.62 | 20159957 | |
| 447 | Ubiquitination | ALRLQDKKLPPLLSE HHHHCCCCCCCHHHH | 74.62 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 426 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NR1H2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...